Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.40 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.40 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.38 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.38 |
| ▸ | FGF1 | P05230 | 1/20 | 0.37 |
| ▸ | FGF2 | P09038 | 1/20 | 0.37 |
| ▸ | VEGFA | P15692 | 1/20 | 0.37 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13080217 | 0.93 | TDP1 (0.48) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL13049592 | 0.93 | TDP1 (0.48) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL3758250 | 0.93 | TDP1 (0.48) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL13049465 | 0.93 | TDP1 (0.48) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL19751702 | 0.91 | TDP1 (0.48) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL4965653 | 0.91 | TDP1 (0.48) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL4962526 | 0.89 | TDP1 (0.50) | TDP1CA12CA1CA2CA9 | |
| SCHEMBL3758247 | 0.85 | TDP1 (0.42) | TDP1CA1CA2PLCD1TPSAB1 | |
| SCHEMBL20123249 | 0.85 | TDP1 (0.42) | TDP1CA1CA2PLCD1TPSAB1 | |
| SCHEMBL13049595 | 0.85 | TDP1 (0.42) | TDP1CA1CA2PLCD1TPSAB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11731982-B2 | Biotin derivatives | Life Technologies Corporation | 2023-08-22 | — | — | US | disclosed |
| US-20190322681-A1 | Biotin Derivatives | LIFE TECHNOLOGIES AS (NO) | 2019-10-24 | — | — | US | disclosed |
| US-20170174700-A1 | Biotin Derivatives | Life Technologies Corporation | 2017-06-22 | — | — | US | disclosed |
| US-9567346-B2 | Biotin derivatives | Life Technologies Corporation (US) | 2017-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731982-B2 | Biotin derivatives | BTD, HLCS, BRI3BP | TDP1 4350/4885CA12 4197/4885CA1 4859/4885 |
| US-20190322681-A1 | Biotin Derivatives | BTD, HLCS, BRI3BP | TDP1 4350/4885CA12 4197/4885CA1 4859/4885 |
| US-20170174700-A1 | Biotin Derivatives | BTD, HLCS, BRI3BP | TDP1 4350/4885CA12 4197/4885CA1 4859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.